Literature DB >> 8822462

Materno-fetal immunoglobulin transfer and passive immunity during the first trimester of human pregnancy.

E Jauniaux1, D Jurkovic, B Gulbis, C Liesnard, C Lees, S Campbell.   

Abstract

Passive transfer of immunity from the mother to the first trimester fetus is of particular interest because of the reported high incidence of serious fetal sequelae due to congenital infection. We have examined the relationship between maternal serum, coelomic fluid and amniotic fluid concentrations of immunoglobulin (Ig) and complement. Ig fractions G (IgG), A (IgA), and M (IgM) and complement factors 3 (C3) and 4 (C4) were measured in 34 normal pregnancies between 6 and 12 weeks of gestation. The concentrations of specific antibodies for Toxoplasma gondii, cytomegalovirus (CMV) and rubella were also measured on 21 matched samples from the same study group. IgG and IgA concentrations were detected in all coelomic fluid samples whereas IgG was only measurable in two amniotic fluid samples. IgG and IgA concentrations were respectively 28 and 128 times lower in coelomic fluid than in maternal serum and probably reflect fetal serum concentrations. Significant positive linear correlations were found between gestational age and the coelomic concentrations of IgG (P = 0.001) and IgA (P = 0.014). There was no obvious association between immunoglobulin concentrations in coelomic fluid and maternal serum suggesting increasing active transport across the placenta with advancing gestation. IgM, C3 and C4 were not detected in coelomic or amniotic fluid samples. Specific antibodies were found in 13 out of 63 samples of coelomic fluid and in 32 out of 63 samples of maternal serum. They were found in coelomic fluid only if they were present in maternal serum. These results suggest that maternal IgG and IgA are potentially available to the embryo as early as the 6th week of gestation. The presence in the coelomic fluid of the IgG fraction, both total and infectious agent-specific transferred via the placenta, indicates that they may provide limited protection against congenital infection in the first trimester.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8822462     DOI: 10.1093/oxfordjournals.humrep.a135906

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  17 in total

Review 1.  The immune response to malaria in utero.

Authors:  Margaret E Feeney
Journal:  Immunol Rev       Date:  2019-09-25       Impact factor: 12.988

2.  The impact of timing of maternal influenza immunization on infant antibody levels at birth.

Authors:  Z Zhong; M Haltalli; B Holder; T Rice; B Donaldson; M O'Driscoll; K Le-Doare; B Kampmann; J S Tregoning
Journal:  Clin Exp Immunol       Date:  2018-12-02       Impact factor: 4.330

3.  Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model.

Authors:  M Haumont; L Delhaye; L Garcia; M Jurado; P Mazzu; V Daminet; V Verlant; A Bollen; R Biemans; A Jacquet
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

4.  Outcomes following biosimilar TNF inhibitor use for inflammatory-mediated immune disorders in pregnancy.

Authors:  R Scott; H Parker; S Mccartney; P Harrow; D Williams; I Giles
Journal:  Obstet Med       Date:  2021-09-02

5.  Preliminary evaluation of the safety and efficacy of standard intravenous immunoglobulins in pregnant women with primary cytomegalovirus infection.

Authors:  Ennio Polilli; Giustino Parruti; Francesca D'Arcangelo; Elisa Tracanna; Luigi Clerico; Vincenzo Savini; Francesco D'Antonio; Maurizio Rosati; Lamberto Manzoli; Domenico D'Antonio; Giovanni Nigro
Journal:  Clin Vaccine Immunol       Date:  2012-10-24

6.  An open-label study in healthy men to evaluate the risk of seminal fluid transmission of denosumab to pregnant partners.

Authors:  Winnie Sohn; Edward Lee; Martin K Kankam; Ogo Egbuna; Graeme Moffat; Jeanine Bussiere; Desmond Padhi; Eric Ng; Sandeep Kumar; J Greg Slatter
Journal:  Br J Clin Pharmacol       Date:  2015-12-05       Impact factor: 4.335

7.  High susceptibility to cytomegalovirus infection of pregnant women in Flanders, Belgium.

Authors:  E Leuridan; M Ieven; N Hens; P Van Damme
Journal:  Facts Views Vis Obgyn       Date:  2012

Review 8.  Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies.

Authors:  Raphael Gorodetsky; Wilhelm K Aicher
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

9.  Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar.

Authors:  Marawan A Abu-Madi; Naema Al-Molawi; Jerzy M Behnke
Journal:  Parasit Vectors       Date:  2008-10-20       Impact factor: 3.876

10.  Lectin-based analysis of fucose and sialic acid expressions on human amniotic IgA during normal pregnancy.

Authors:  Magdalena Orczyk-Pawiłowicz; Daria Augustyniak; Lidia Hirnle; Iwona Kątnik-Prastowska
Journal:  Glycoconj J       Date:  2012-12-19       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.